BMI OrganBank™ has partnered on a $1.5 million project to develop innovative methods for preserving human limbs for transplantation. The research aims to extend tissue viability, enhancing transplant outcomes for critical tissues like skin, bone, and nerves. This breakthrough has the potential to significantly impact the NSF Innovation Engine’s goals by contributing to advancements in regenerative medicine and transplantation technology, further driving progress in biomedical research.
“This project is a true collaborative effort, bringing together a multidisciplinary team from two academic institutions and two industry leaders. Project leader Dr. Jelena Janjic’s partnership with Dr. Vijay S. Gorantla from the Wake Forest Institute for Regenerative Medicine will focus on evaluating the effectiveness of the novel therapies developed at Duquesne. This collaboration with Faron Pharmaceuticals, led by CEO Dr. Juho Jalkanen, will leverage cutting-edge therapeutics for vascular protection alongside our organ preservation technologies.”
Read more at bmiorganbank.com.